← Back to Clinical Trials
Recruiting NCT03481881
NCT03481881 Pharmacokinetics of Drugs Administered to Children
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT03481881 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Pediatric ALL |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2013-08-14 |
| Primary Completion | 2033-08-14 |
Trial Parameters
Condition Pediatric ALL
Sponsor Duke University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 0 Years
Max Age 20 Years
Start Date 2013-08-14
Completion 2033-08-14
Interventions
Standard of care drug
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
Eligibility Criteria
Inclusion Criteria: * Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver Exclusion Criteria: * Failure to obtain consent/assent (as indicated)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology